IL2 and neoplasm: Several recent approaches have been taken to target IL-2 and other cytokines to specific locations, such as the tumor microenvironment (Hutmacher et al., 2019; Mortara et al., 2018; Ongaro et al., 2020; Silver et al., 2021).